06 Oct neurodAIgnostics joins the USZ Health Innovation Hub portfolio
neurodAIgnostics is proud to announce its selection to the portfolio of the Health Innovation Hub of the University Hospital Zurich (USZ), a strategic initiative dedicated to advancing high-impact healthcare innovation and entrepreneurship.
As one of the world’s leading university hospitals and a center of excellence in medical research, USZ established the Health Innovation Hub to accelerate the development of innovative, patient-centered solutions that go beyond research and translate into real-world clinical impact. The Hub supports startups and innovators with commercially viable ideas and open-access projects alike, fostering close collaboration with USZ to improve recovery outcomes and enhance patients’ quality of life, while strengthening Switzerland’s position as a global leader in medical innovation.